Screener
Pulse Biosciences, Inc. PLSE Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $101.62M-4.4% | $68.32M-42.7% | $80.74M-31.6% | $95.21M+20.5% | $106.35M+306% | ||
| $122K— | $157K— | $274K— | $15K— | -$0— | ||
| $236K+363% | $206K+587% | $136K— | $57K— | $51K— | ||
| $105.7M-2.3% | $71.13M-41.2% | $83.42M-30.2% | $97.16M+20.8% | $108.16M+297% | ||
| $1.06M-4.1% | $1.02M-4.3% | $1.05M-9.4% | $1.06M-13.6% | $1.11M-15.5% | ||
| $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | ||
| $222K-75.5% | $408K-61.3% | $575K-52.9% | $741K-46.5% | $907K-41.6% | ||
| $115.56M-3.9% | $81.62M-38.8% | $94.54M-28.6% | $108.77M+16.9% | $120.25M+197% | ||
| $2.83M+3.3% | $2.76M+16.5% | $2.78M+66.0% | $2.98M+72.4% | $2.74M+67.5% | ||
| $10.98M+22.3% | $9.8M+26.2% | $7.92M-21.2% | $9.7M+43.9% | $8.98M+50.6% | ||
| $16.06M+1.9% | $15.32M+2.6% | $13.88M-21.1% | $16.07M+15.5% | $15.76M+17.1% | ||
| $71K+6.0% | $68K+1.5% | $68K+3.0% | $68K+9.7% | $67K+21.8% | ||
| -$506.52M-18.8% | -$481.86M-18.3% | -$463.28M-18.6% | -$445.85M-20.1% | -$426.46M-19.0% | ||
| $99.5M-4.8% | $66.3M-44.0% | $80.66M-29.8% | $92.69M+17.1% | $104.49M+287% | ||
| $115.56M-3.9% | $81.62M-38.8% | $94.54M-28.6% | $108.77M+16.9% | $120.25M+197% |
FAQ
- What are Pulse Biosciences, Inc.'s total assets?
- Pulse Biosciences, Inc. (PLSE) holds $115.6M in total assets, down 3.9% year over year.
- How much debt does Pulse Biosciences, Inc. have?
- Pulse Biosciences, Inc. carries $6.8M in total debt against $99.5M of shareholders' equity, a debt-to-equity ratio of 0.07.
- How much cash does Pulse Biosciences, Inc. have?
- Pulse Biosciences, Inc. holds $101.6M in cash and equivalents.
- Can Pulse Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 9.63 — current assets exceed current liabilities.
- Where does Pulse Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
